Literature DB >> 29692690

Overactive Bladder Syndrome: Evaluation and Management.

Elad Leron1, Adi Y Weintraub1, Salvatore A Mastrolia1,2, Polina Schwarzman1.   

Abstract

Overactive bladder (OAB) syndrome is a chronic medical condition which has a major influence on the quality of life in a significant amount of the population. OAB affects performance of daily activities and has an estimated prevalence of 16.5%. Many sufferers do not seek medical help. Moreover, many family physicians and even gynecologists are not familiar with this issue. Usually patients suffer from OAB in advanced age. Nocturia is reported as the most bothersome symptom in the elderly population. The aim of our review was to discuss all aspects of this challenging disorder and suggest tools for assessment and management strategies. Practitioners can easily overlook urinary complains if they not directly queried. We would like to encourage practitioners to give more attention to this issue.

Entities:  

Keywords:  Aging; Antimuscarinic drugs; Nocturia; Overactive bladder syndrome; Overactive detrusor muscle

Year:  2018        PMID: 29692690      PMCID: PMC5903463          DOI: 10.1159/000447205

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  57 in total

1.  Antimuscarinic drugs to treat overactive bladder.

Authors:  Dudley Robinson; Linda Cardozo
Journal:  BMJ       Date:  2012-03-27

2.  Clinical guidelines for overactive bladder.

Authors:  Osamu Yamaguchi; Osamu Nishizawa; Masayuki Takeda; Osamu Yokoyama; Yukio Homma; Hidehiro Kakizaki; Kenji Obara; Momokazu Gotoh; Yasuhiko Igawa; Naarihito Seki; Masaki Yoshida
Journal:  Int J Urol       Date:  2009-02       Impact factor: 3.369

3.  Overactive bladder inhibition in response to pelvic floor muscle exercises.

Authors:  Ahmed Shafik; Ismail A Shafik
Journal:  World J Urol       Date:  2003-04-04       Impact factor: 4.226

Review 4.  Detrusor myocyte activity and afferent signaling.

Authors:  Karl-Erik Andersson
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  Combined behavioral and drug therapy for urge incontinence in older women.

Authors:  K L Burgio; J L Locher; P S Goode
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

Review 6.  Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review.

Authors:  Peter Herbison; Jean Hay-Smith; Gaye Ellis; Kate Moore
Journal:  BMJ       Date:  2003-04-19

Review 7.  The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis.

Authors:  Christopher R Chapple; Vik Khullar; Zahava Gabriel; Dominic Muston; Caty Ebel Bitoun; David Weinstein
Journal:  Eur Urol       Date:  2008-06-20       Impact factor: 20.096

8.  Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.

Authors:  Vik Khullar; Gerard Amarenco; Javier C Angulo; Javier Cambronero; Kjetil Høye; Ian Milsom; Piotr Radziszewski; Tomasz Rechberger; Peter Boerrigter; Ted Drogendijk; Marianne Wooning; Christopher Chapple
Journal:  Eur Urol       Date:  2012-11-06       Impact factor: 20.096

Review 9.  Refractory overactive bladder in men: update on novel therapies.

Authors:  Casey K Ng; Ricardo R Gonzalez; Alexis E Te
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

10.  Effect of caffeine on bladder function in patients with overactive bladder symptoms.

Authors:  Supatra Lohsiriwat; Muthita Hirunsai; Bansithi Chaiyaprasithi
Journal:  Urol Ann       Date:  2011-01
View more
  17 in total

Review 1.  How I Handle Retreatment of LUTS Following a Failed MIST.

Authors:  Alexis E Te; Ahra Cho; Bilal I Chughtai
Journal:  Curr Urol Rep       Date:  2021-06-11       Impact factor: 3.092

2.  The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan.

Authors:  Yoshiharu Okuyama; Teppei Okamoto; Daichi Sasaki; Kai Ozaki; Jung Songee; Shingo Hatakeyama; Tatsuya Mikami; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2021-10-29       Impact factor: 2.370

Review 3.  Advances in Assistive Electronic Device Solutions for Urology.

Authors:  Kieran Holmes-Martin; Minghui Zhu; Shujun Xiao; Faezeh Arab Hassani
Journal:  Micromachines (Basel)       Date:  2022-03-30       Impact factor: 3.523

4.  Prophylactic diphenhydramine attenuates postoperative catheter-related bladder discomfort in patients undergoing gynecologic laparoscopic surgery: a randomized double-blind clinical study.

Authors:  Yu-Yu Li; Yan-Syun Zeng; Jen-Yin Chen; Kuei-Fen Wang; Chung-Hsi Hsing; Wen-Ju Wu; Jhi-Joung Wang; Ping-Hsun Feng; Chin-Chen Chu
Journal:  J Anesth       Date:  2019-12-20       Impact factor: 2.078

5.  Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.

Authors:  Nandita Kachru; Holly M Holmes; Michael L Johnson; Hua Chen; Rajender R Aparasu
Journal:  Curr Med Res Opin       Date:  2021-05-13       Impact factor: 2.705

Review 6.  Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review.

Authors:  Silvia Joseph; Steffi A Maria; Jacob Peedicayil
Journal:  Curr Ther Res Clin Exp       Date:  2022-04-06

7.  Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.

Authors:  Vinit Kumar Srivastava; Sanjay Agrawal; Sweta Anil Deshmukh; Febin Noushad; Saima Khan; Raj Kumar
Journal:  Korean J Anesthesiol       Date:  2019-10-11

8.  Vitamin D and thiol-disulfide homeostasis levels in postmenopausal women with overactive bladder syndrome.

Authors:  Yasemin Ustundag; Karlıbel Lknur Aykurt; Murat Sambel; Murat Ozturk; Atilla Satır; Elif Yolgosteren; Salim Neselioglu; Ozcan Erel
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

9.  O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment.

Authors:  Andrzej Wróbel; Anna Serefko; Aleksandra Szopa; Daniela Ulrich; Ewa Poleszak; Tomasz Rechberger
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

10.  Prevalence and associated risk factors among patients with overactive bladder syndrome in Pakistan.

Authors:  Sajid Rashid; Muhammad Naveed Babur; Rehan Ramzan Khan; Muhammad Usman Khalid; Haroon Mansha; Saima Riaz
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.